What is the current price of Nippon India Nifty Pharma ETF?
The current price of Nippon India Nifty Pharma ETF is ₹29.54 as of 11th November 2026.What is the AUM of Nippon India Nifty Pharma ETF?
The AUM (i.e. assets under management) of Nippon India Nifty Pharma ETF is ₹1756.56 Cr as of 11th November 2026.What are the returns of Nippon India Nifty Pharma ETF?
The past returns of Nippon India Nifty Pharma ETF are as follows:- Past 1 week | 5.61%
- Past 1 month | 10.35%
- Past 3 months | 7.46%
- Past 6 months | 19.06%
- Past 1 year | 28.94%
- Past 3 years | 87.56%
- Past 5 years | 114.21%
What is the Riskomenter level for Nippon India Nifty Pharma ETF?
The Riskometer reading of Nippon India Nifty Pharma ETF is 1.00.What is the expense ratio of Nippon India Nifty Pharma ETF?
The expense ratio of Nippon India Nifty Pharma ETF is 0.23 as of 11th November 2026.
₹29.540.61% (-0.18)
Tracking Nifty Pharma Index
Scorecard
Performance
AvgReturn has been average, nothing exciting vs others
Risk
LowStay at ease, amongst the lower risk ETFs
Cost
HighHigher costs on pocket vs others
Entry point
HighThe ETF is in the overbought zone
How to use scorecard? Learn more
Nippon India Nifty Pharma ETF
PHARMABEES Share Price
NSENippon India Nifty Pharma ETF
PHARMABEES Share Price
ETF
Tracking Nifty Pharma Index
ETFEquity
Multicap ETF
High LiquidityAverage daily traded value of the ETF is high
₹29.540.61% (-0.18)
₹29.540.61% (-0.18)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
5Y
Max
SIP
Scorecard
Performance
AvgReturn has been average, nothing exciting vs others
Risk
LowStay at ease, amongst the lower risk ETFs
Cost
HighHigher costs on pocket vs others
Entry point
HighThe ETF is in the overbought zone
How to use scorecard? Learn more
Nippon India Nifty Pharma ETF Performance & Key Metrics
Nippon India Nifty Pharma ETF Performance & Key Metrics
| Realtime NAVRealtime NAV | AUMAUM | Expense RatioExpense Ratio |
|---|---|---|
| — | ₹ 1,756.56cr | 0.23% |
| Sector Expense RatioSctr Expense Ratio | Tracking ErrorTracking Error | Sector Tracking ErrorSctr Tracking Error |
|---|---|---|
| 0.44% | 0.02% | 2.41% |
AMC Details for Nippon India Nifty Pharma ETF
AMC Details for Nippon India Nifty Pharma ETF
Nippon India Mutual Fund is one of India’s leading mutual funds, with Average Assets Under Management (AAUM) of Rs 2,79,431 Crores. NIMF has been established as a trust under the Indian Trusts Act, 1882 with Nippon Life Insurance Company as its Sponsor and Nippon Life India Trustee Ltd as its Trustee.
PHARMAIETF
Tracking Error
0.59%
0.59%
Expense Ratio
0.25%
0.25%
1Y Return
7.43%
7.43%
Nippon India Nifty Pharma ETF Peers
What are peers and why compare against them?
What are peers and why compare against them?
An ETF's peers are ETFs which have the same underlying index. Comparing various metrics against peers can give valuable insights on how the ETF is performing and ETF's growth as compared to other ETF's that are tracking the same index.
Nippon India Nifty Pharma ETF Peers & Comparison
Nippon India Nifty Pharma ETF Peers & Comparison
Comparing 1 ETFs
tracking Nifty Pharma Index
| ETF | Tracking ErrorTracking Error | Expense RatioExpense Ratio | LiquidityLiquidity |
|---|---|---|---|
| Nippon India Nifty Pharma ETF | 0.02% | 0.23% | High |
| ICICI Prudential Nifty Pharma ETF | 0.59% | 0.25% | High |
Compare ETFs on ScreenerNippon India Nifty Pharma ETF Price Comparison
Compare PHARMABEES with any stock or ETFCompare PHARMABEES with any stock or ETF
PHARMABEES
Nippon India Nifty Pharma ETF Related News & Opinions
Nippon India Nifty Pharma ETF Related News & Opinions
Articles & Videos
Market Trading Guide: Astra Microwave among 3 stock recommendations for Thursday - Buy CDSL at Rs 1408 - Stop loss: Rs 1335 - Target: Rs 1554
in 3 hours•Economic Times
Sensex Surges 1,350 Points, Nifty Tops 25,400 To Hit Eight-Month Highs
12 hours ago•Free Press Journal
Market wrap: SBI, Trent, Tata Steel, HCL Tech top gainers and losers on Nifty and Sensex on Monday
2 days ago•Economic Times
Market Update: Sensex Turns Green To Reclaim 81,000, Nifty Nears 25,000 As Banking, Pharma Stocks Drive Recovery
2 days ago•News18
Nifty slips to 24,882 at midday; IT, Steel, Cement drag as Rupee hits 2026 high
2 days ago•The Hindu Businessline
Pharma shares shine: Sai, Gland, Divi’s, Laurus, Glenmark surge up to 9%
2 days ago•Business Standard
Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoY
2 days ago•Economic Times
Muhurat Trading 2026 Highlights: Sensex, Nifty End Flat During Special Diwali Session; Smallcaps Rally Up To 1.4%
3 days ago•News18
Pharma industry steps up API investments to cut import dependence, move up value chain
4 days ago•Economic Times
Pharma stocks rally: Aurobindo, Divi’s, Glenmark, Symbiotec hit new highs
5 days ago•Business Standard
Nippon India Nifty Pharma ETF Events
Nippon India Nifty Pharma ETF Events
Dividends
Corp. Actions
Announcements
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
Nippon India Nifty Pharma ETF Upcoming Dividends
Nippon India Nifty Pharma ETF Upcoming Dividends
No upcoming dividends are available
Nippon India Nifty Pharma ETF Past Dividends
Nippon India Nifty Pharma ETF Past Dividends
Cash DividendAUROPHARMA
AUROPHARMAEx DateEx DateNov 11, 2026
Interim
Interim | Div/Share: ₹7.00
Dividend/Share
₹7.00
Ex DateEx Date
Nov 11, 2026
Cash DividendLAURUSLABS
LAURUSLABSEx DateEx DateNov 6, 2026
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 6, 2026
Cash DividendGLENMARK
GLENMARKEx DateEx DateAug 31, 2026
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Aug 31, 2026
Cash DividendGLAND
GLANDEx DateEx DateAug 11, 2026
Final
Final | Div/Share: ₹20.00
Dividend/Share
₹20.00
Ex DateEx Date
Aug 11, 2026
Cash DividendALKEM
ALKEMEx DateEx DateAug 7, 2026
Final
Final | Div/Share: ₹10.00
Dividend/Share
₹10.00
Ex DateEx Date
Aug 7, 2026
